X3Y-70977-20325
2 vaccinations
2 coded responses
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 432 / OH
- Registered
- 2022-08-04
- Relationship
- Child or adolescent in my care
- Guardian
- 69B-27556-58617
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-30
Dose 1 — Moderna
-
2022-08-03
Dose 2 — Moderna
-
2022-08-04
Registered in v-safe
- 2022-08-04
- 2022-08-05
- 2022-08-08
- 2022-08-09
- 2022-08-11
- 2022-08-18
- 2022-08-24
-
2022-08-31
Survey response — day 28, dose 2, under 3MedDRA: Rhinorrhoea, Somnolence — Feeling: Good · Be unable to work or attend schoolFree text: Runny nose, excessive sleepinessesMedDRA releases: 2024-11 · check-in free text available
- 2022-09-07
- 2022-09-16
-
2023-02-01
Survey response — 6 months, dose 2, under 3MedDRA: Eczema, Self-medication — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-30 | Moderna | No |
| 2 | 2022-08-03 | Moderna | No |
Free text
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Runny nose, excessive sleepinesses
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eczema | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release